Amongst the flurry of efforts to combat the West African Ebola outbreak, Johnson & Johnson is trying its hand at developing a vaccine

Johnson & Johnson To Fast Track Ebola Vaccine Trials

Amongst the flurry of efforts to combat the West African Ebola outbreak,┬áJohnson & Johnson is trying its hand at developing a vaccine Johnson & Johnson can be counted amongst the ranks of yet another pharmaceutical company that has joined the race to develop an Ebola vaccine. Thus far, the most advanced vaccine candidate is Glaxo Smith Kline’s, which is the …

Presentation download: Developing strategic partnerships with external manufacturers

Here is a presentation by Mr Timo Simmen, Director, Projects, Global Technical Services at Johnson & Johnson on developing strategic partnerships with external manufacturers on vaccine manufacturing. He made this presentation at World Vaccine Congress Asia this year. The presentation focuses on the evaluating criteria for strategic partnership in pharmaceutical manufacturing and how one should understand the selection process for …

How can breakthrough technology serve the emerging markets?

In January 2010 Johan Van Hoof was appointed Global Therapeutic Area Head for Infectious Diseases & Vaccines, Pharmaceuticals Group, JnJ. As of June 2011, Johan took additional responsibilities, as COO Crucell, the Vaccine Company acquired by JnJ in February 2011. In this role he oversees Development and Manufacturing as Crucell. Entering the field of vaccines, J&J aims to broaden its …